A new report finds there are fewer antibacterial medicines in clinical pipelines than just two years ago and relatively few ...
President Trump announced that Pfizer agreed to offer lower prices on its drugs to the Medicaid program and directly to ...
WASHINGTON — President Trump told pharmaceutical companies last week that they should start building infrastructure in the ...
Researchers have found that ALS patients have autoimmune responses, a finding with the potential to reshape how scientists ...
Patient groups urge U.K.’s antitrust regulator to investigate drugmakers for “suspected” and “coordinated” efforts to drive up the prices of medicines.
Good morning. The government is shut down, but the First Opinion Podcast is back. Take a listen.
Leucovorin has a place in autism treatment, researcher says, but he tamps down parents’ expectations
STAT spoke with Robert Hendren, a retired UCSF researcher who conducted a small study of leucovorin in children with autism in 2020.
I'm never going to speak to everyone. We need a much greater diversity of science communicators and researchers and experts making content,” Dr. Noc says on the “First Opinion Podcast.” ...
The only way for work requirements to shrink the Medicaid rolls by inducing people to work is to get them to take jobs that come with insurance benefits. Getting them to drop out of Medicaid and ...
A new study found that an AI “safety net” reduced diagnostic errors by 16% and treatment errors by 13% — but also created new challenges.
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Democrats and Republicans clashed over enhanced ACA subsidies, and failed to reach a deal to fund the government.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback